Shares of Synairgen PLC (LON: SNG) have exploded nearly 400% to 180p after the drugmaker revealed positive results from a clinical trial of its drug for the treatment of the severe symptoms of COVID-19 disease.
The firm said that 79% of tested patients showed a “lower risk of developing severe disease compared to those given the placebo”.
“Our efforts are now focused on working with the regulators and other key groups to progress this potential COVID-19 treatment as rapidly as possible,” chief executive Richard Marsden said.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
SNG001, a test drug developed to treat positive patients with more severe symptoms, has also proved successful in ramping up the recovery from the COVID-19 virus. Patients who received the drug were more than twice as likely to recover from the illness than those that received the placebo.
Synairgen share price exploded almost 400% today on the news. Despite the rapid ascendance, analysts believe that the upside may be much higher for the stock.
Mark Brewer, the analyst at finnCap, increased his target for Synairgen stock price to 360p. The set target price represents a premium of 886% from Friday’s close of 36.5p.
